Access to anti-retroviral drugs, male in Azerbaijan
Azerbaijan: Access to anti-retroviral drugs, male was 80.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Azerbaijan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Azerbaijan is 80.0%, measured in 2024. That is the highest value across all 24 years on record.
Compared with earlier readings it is up 14.3% on the previous year and up 321.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Azerbaijan peaked at 80.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Azerbaijan 47th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Azerbaijan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 1.0% | — |
| 2008 | 2.0% | +100.0% |
| 2009 | 3.0% | +50.0% |
| 2010 | 5.0% | +66.7% |
| 2011 | 9.0% | +80.0% |
| 2012 | 11.0% | +22.2% |
| 2013 | 15.0% | +36.4% |
| 2014 | 19.0% | +26.7% |
| 2015 | 25.0% | +31.6% |
| 2016 | 29.0% | +16.0% |
| 2017 | 34.0% | +17.2% |
| 2018 | 40.0% | +17.6% |
| 2019 | 50.0% | +25.0% |
| 2020 | 55.0% | +10.0% |
| 2021 | 60.0% | +9.1% |
| 2022 | 61.0% | +1.7% |
| 2023 | 70.0% | +14.8% |
| 2024 | 80.0% | +14.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.7% | 0.0% | 3.0% | 9 |
| 2010s | 23.7% | 5.0% | 50.0% | 10 |
| 2020s | 65.2% | 55.0% | 80.0% | 5 |
Countries ranked near Azerbaijan
More gender data for Azerbaijan
- Child population (UN estimates and projections) 1,956 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.3 % change on previous year (2030)
- Population 8,710 (2030)
- Working-age population (UN estimates and projections) 8,710 (2030)
- Population (UN estimates and projections), annual growth rate 1.12 % change on previous year (2030)
- Age population, age 00, female, interpolated 56,657 (2025)
- Age population, age 00, male, interpolated 62,813 (2025)
- Age population, age 01, female, interpolated 57,383 (2025)
- Age population, age 01, male, interpolated 63,829 (2025)
- Age population, age 02, female, interpolated 58,825 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Azerbaijan?
- Access to anti-retroviral drugs, male in Azerbaijan was 80.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Azerbaijan?
- The highest recorded value was 80.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Azerbaijan?
- The lowest recorded value was 0.0% in 2000.
- How does Azerbaijan rank for access to anti-retroviral drugs, male?
- Azerbaijan ranks 47th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Azerbaijan?
- Over the last ten years it is up 321.1%. The long-run trend across the full record is volatile.
- Where does this Azerbaijan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.